Company / Working Capital per Share
Arbutus Biopharma Corp Working Capital per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital per Share
$0.47
FY2025
5-year range
$0.47 / $1.67
FY2021-FY2025
Trend
-29.2%
vs FY2024
Sector context
#195 of 210
Health Care
What the data says
Among 210 Health Care companies, Arbutus Biopharma Corp is in the bottom 7% for working capital per share. Working Capital per Share has declined for 5 consecutive years, from $1.82 in FY2020 to $0.47 in FY2025.
Based on SEC 10-K filings.
0.47 in FY2025 with a 5-year CAGR of -23.9%.
Declined from $0.70 to $0.47 over the past 2 years.
Health Care sector context is included.
Working Capital per Share over time
Growth rates
- 3-Year CAGR
- -17.1%
- 5-Year CAGR
- -23.9%
- 10-Year CAGR
- -
Sector benchmark
Bottom 7% in Health CareTop 93% of 210This company $0.47 Sector average $146.86
▼
-99.7% below sector average
Key checks
Key Insights
- Arbutus Biopharma Corp's working capital per share has declined for 5 consecutive years.
- In FY2025, working capital per share decreased 29.2% year-over-year.
- Ranks #195 out of 210 companies in the Health Care sector.
- Peak working capital per share was recorded in FY2016.
Company context
Key Data Points
- Altman Z-Score -11.01 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working Capital per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.47 | -29.2% |
| FY2024 | $0.66 | -5.5% |
| FY2023 | $0.70 | -14.7% |
| FY2022 | $0.82 | -51.0% |
| FY2021 | $1.67 | -8.6% |
| FY2020 | $1.82 | +17.8% |
| FY2019 | $1.55 | -27.7% |
| FY2018 | $2.14 | +2.8% |
| FY2017 | $2.08 | -6.3% |
| FY2016 | $2.22 | -30.0% |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026